REQUEST A DEMO
Total
USD $0.00
Search more companies

Lekaren Sustekova, s.r.o. (Slovakia)

Main Activities: Pharmacies and Drug Stores
Full name: Lekaren Sustekova, s.r.o. Profile Updated: November 28, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Lekaren Sustekova, s.r.o. is an enterprise in Slovakia, with the main office in Bratislava. The company operates in the Pharmacies and Drug Stores sector. It was incorporated on October 12, 2004. Lekaren Sustekova, s.r.o. currently employs 10 - 19 (2023) people. There was a net sales revenue drop of 13% reported in Lekaren Sustekova, s.r.o.’s latest financial highlights for 2023. Its’ total assets recorded a negative growth of 9.35%. In 2023, Lekaren Sustekova, s.r.o.’s net profit margin decreased by 1.66%.

Headquarters
Digital Park II, Einsteinova 23
Bratislava; Bratislavsky; Postal Code: 85101

Contact Details: Purchase the Lekaren Sustekova, s.r.o. report to view the information.

Basic Information
Total Employees:
Purchase the Lekaren Sustekova, s.r.o. report to view the information.
Outstanding Shares:
Purchase the Lekaren Sustekova, s.r.o. report to view the information.
Registered Capital:
Purchase the Lekaren Sustekova, s.r.o. report to view the information.
Incorporation Date:
October 12, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Lekaren Sustekova, s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-13%
Total operating revenue
-12.81%
Operating profit (EBIT)
-62.54%
EBITDA
-0.42%
Net Profit (Loss) for the Period
-68.4%
Total assets
-9.35%
Total equity
8.51%
Operating Profit Margin (ROS)
-1.86%
Net Profit Margin
-1.66%
Return on Equity (ROE)
-19.08%
Debt to Equity Ratio
0.2%
Quick Ratio
-0.18%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?